(VIANEWS) – Innrs Artificial Intelligence has been accurately guessing the intraday stock prices and making several successful predictions.
Via News will publish the daily results of this AI algorithm.
If an investor followed the Innrs AI suggestion, yesterday’s AI investment would yield a 0.15% ROI.
The table below shows the data.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| Zillow Group (Z) | 83.61% | $43.81 | 4.14% ✅ |
| Burlington Stores (BURL) | 88.78% | $121.12 | 3.25% ✅ |
| Electronic Arts (EA) | 83.39% | $128.36 | 3.21% ✅ |
| Cliffs Natural Resources (CLF) | 89.23% | $15.36 | 2.62% ✅ |
| CME Group (CME) | 83.81% | $214.8 | 2.61% ✅ |
| Xerox Corporation (XRX) | 89.32% | $14.98 | 2.15% ✅ |
| Bio-Techne Corp (TECH) | 89.25% | $68.53 | 1.89% ✅ |
| Bio-Techne Corp (TECH) | 89.17% | $68.6 | 1.76% ✅ |
| Zillow Group (Z) | 83.64% | $45.39 | 1.73% ✅ |
| Alnylam Pharmaceuticals (ALNY) | 88.18% | $172.81 | 1.64% ✅ |
| Xerox Corporation (XRX) | 89.34% | $14.92 | 1.32% ✅ |
| Graham Holdings Company (GHC) | 83.36% | $598.88 | 1.28% ✅ |
| Dow Chemical Company (DOW) | 84.26% | $50.8 | 1.22% ✅ |
| Intuitive Surgical (ISRG) | 83.17% | $302.69 | 1.12% ✅ |
| E.I. du Pont de Nemours and Company (DD) | 83.43% | $76.35 | 1.11% ✅ |
| CME Group (CME) | 88.86% | $217.58 | 0.87% ✅ |
| E.I. du Pont de Nemours and Company (DD) | 83.43% | $77.15 | 0.85% ✅ |
| Graham Holdings Company (GHC) | 88.47% | $603.58 | 0.77% ✅ |
| Biogen (BIIB) | 84.06% | $269.05 | 0.51% ✅ |
| Ross Stores (ROST) | 83.74% | $115.87 | 0.14% ✅ |
| Burlington Stores (BURL) | 88.71% | $124.61 | 0.03% ✅ |
| FAT Brands (FAT) | 83.58% | $6.56 | -0.31% |
| Pfizer (PFE) | 83.7% | $34.02 | -0.33% |
| Banco Santander (SAN) | 84.03% | $3.8 | -0.53% |
| Live Nation Entertainment (LYV) | 89.04% | $89.8 | -0.69% |
| Nokia (NOK) | 87.33% | $3.42 | -0.84% |
| Cadence Design Systems (CDNS) | 83.46% | $244 | -0.9% |
| Live Nation Entertainment (LYV) | 84.01% | $88.85 | -1.07% |
| Globalstar (GSAT) | 83.48% | $1.41 | -1.43% |
| Sabre Corporation (SABR) | 83.57% | $3.5 | -1.8% |
| Ericsson (ERIC) | 88.21% | $4.61 | -2.11% |
| Brandywine Realty Trust (BDN) | 87.83% | $3.95 | -3.29% |
| Antero Resources (AR) | 88.35% | $25.83 | -4.79% |
| Sabre Corporation (SABR) | 83.52% | $3.5 | -5.05% |
| Alnylam Pharmaceuticals (ALNY) | 83.27% | $185.25 | -5.7% |
1. Zillow Group (Z)
Zillow Group has been having an accuracy rate of 83.61% over the last 10 sessions. Previous close price was $43.51 the AI prediction was $43.81 and today’s closing price was $45.31. The intraday ROI for Zillow Group (Z) was 4.14%.
Shares of Zillow Group fell by a staggering 15.01% in from $52.59 to $44.70 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.58% to $13,562.84, after three successive sessions in a row of gains.
Zillow Group, Inc. operates real estate brands on mobile applications and Websites in the United States.
Earnings Per Share
As for profitability, Zillow Group has a trailing twelve months EPS of $-0.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.93%.
Volume
Today’s last reported volume for Zillow Group is 617585 which is 75.41% below its average volume of 2512070.
Moving Average
Zillow Group’s worth is way under its 50-day moving average of $50.42 and below its 200-day moving average of $46.03.
Yearly Top and Bottom Value
Zillow Group’s stock is valued at $44.70 at 22:29 EST, way below its 52-week high of $57.19 and way higher than its 52-week low of $26.14.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Zillow Group’s stock is considered to be overbought (>=80).
More news about Zillow Group.
2. Burlington Stores (BURL)
Burlington Stores has been having an accuracy rate of 88.78% over the last 10 sessions. Previous close price was $119.83 the AI prediction was $121.12 and today’s closing price was $123.72. The intraday ROI for Burlington Stores (BURL) was 3.25%.
Shares of Burlington Stores fell by a staggering 25.84% in from $167.13 to $123.94 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is rising 0.86% to $15,450.24, after five successive sessions in a row of gains.
Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States.
Earnings Per Share
As for profitability, Burlington Stores has a trailing twelve months EPS of $3.98.
PE Ratio
Burlington Stores has a trailing twelve months price to earnings ratio of 31.14. Meaning, the purchaser of the share is investing $31.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.39%.
More news about Burlington Stores.
3. Electronic Arts (EA)
Electronic Arts has been having an accuracy rate of 83.39% over the last 10 sessions. Previous close price was $124.1 the AI prediction was $128.36 and today’s closing price was $128.08. The intraday ROI for Electronic Arts (EA) was 3.21%.
Shares of Electronic Arts jumped 4.79% in from $122.77 to $128.65 at 22:29 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is rising 0.58% to $13,562.84, after three successive sessions in a row of gains.
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide.
Earnings Per Share
As for profitability, Electronic Arts has a trailing twelve months EPS of $3.24.
PE Ratio
Electronic Arts has a trailing twelve months price to earnings ratio of 39.71. Meaning, the purchaser of the share is investing $39.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.93%.
More news about Electronic Arts.
4. Cliffs Natural Resources (CLF)
Cliffs Natural Resources has been having an accuracy rate of 89.23% over the last 10 sessions. Previous close price was $15.25 the AI prediction was $15.36 and today’s closing price was $15.65. The intraday ROI for Cliffs Natural Resources (CLF) was 2.62%.
Shares of Cliffs Natural Resources jumped by a staggering 12.09% in from $14.14 to $15.85 at 22:29 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
Cleveland-Cliffs Inc. operates as a flat-rolled steel producer in North America.
Earnings Per Share
As for profitability, Cliffs Natural Resources has a trailing twelve months EPS of $0.47.
PE Ratio
Cliffs Natural Resources has a trailing twelve months price to earnings ratio of 33.71. Meaning, the purchaser of the share is investing $33.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.63%.
Yearly Top and Bottom Value
Cliffs Natural Resources’s stock is valued at $15.85 at 22:29 EST, way under its 52-week high of $22.83 and way above its 52-week low of $11.83.
Moving Average
Cliffs Natural Resources’s value is above its 50-day moving average of $15.19 and under its 200-day moving average of $17.01.
More news about Cliffs Natural Resources.
5. CME Group (CME)
CME Group has been having an accuracy rate of 83.81% over the last 10 sessions. Previous close price was $210.59 the AI prediction was $214.8 and today’s closing price was $216.09. The intraday ROI for CME Group (CME) was 2.61%.
Shares of CME Group jumped 5.84% in from $205.87 to $217.89 at 22:29 EST on Tuesday, after five successive sessions in a row of gains. NASDAQ is jumping 0.58% to $13,562.84, after three successive sessions in a row of gains.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
Earnings Per Share
As for profitability, CME Group has a trailing twelve months EPS of $8.19.
PE Ratio
CME Group has a trailing twelve months price to earnings ratio of 26.6. Meaning, the purchaser of the share is investing $26.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.67%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CME Group’s EBITDA is 59.59.
More news about CME Group.
6. Xerox Corporation (XRX)
Xerox Corporation has been having an accuracy rate of 89.32% over the last 10 sessions. Previous close price was $15.32 the AI prediction was $14.98 and today’s closing price was $14.99. The intraday ROI for Xerox Corporation (XRX) was 2.15%.
Shares of Xerox Corporation fell by a staggering 11.69% in from $17.04 to $15.05 at 22:29 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.86% to $15,450.24, after five successive sessions in a row of gains.
Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the Americas, Europe, the Middle East, Africa, India, and internationally.
Earnings Per Share
As for profitability, Xerox Corporation has a trailing twelve months EPS of $-1.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.45%.
More news about Xerox Corporation.
7. Bio-Techne Corp (TECH)
Bio-Techne Corp has been having an accuracy rate of 89.25% over the last 10 sessions. Previous close price was $68.12 the AI prediction was $68.53 and today’s closing price was $69.41. The intraday ROI for Bio-Techne Corp (TECH) was 1.89%.
Shares of Bio-Techne Corp slid 2.21% in from $71.14 to $69.57 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.58% to $13,562.84, after three sequential sessions in a row of gains.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally.
Earnings Per Share
As for profitability, Bio-Techne Corp has a trailing twelve months EPS of $1.76.
PE Ratio
Bio-Techne Corp has a trailing twelve months price to earnings ratio of 39.53. Meaning, the purchaser of the share is investing $39.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.57%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Bio-Techne Corp’s EBITDA is 108.57.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 1.14B for the twelve trailing months.
More news about Bio-Techne Corp.
8. Bio-Techne Corp (TECH)
Bio-Techne Corp has been having an accuracy rate of 89.17% over the last 10 sessions. Previous close price was $68.21 the AI prediction was $68.6 and today’s closing price was $69.41. The intraday ROI for Bio-Techne Corp (TECH) was 1.76%.
Shares of Bio-Techne Corp fell 2.21% in from $71.14 to $69.57 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is jumping 0.58% to $13,562.84, after three successive sessions in a row of gains.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally.
Earnings Per Share
As for profitability, Bio-Techne Corp has a trailing twelve months EPS of $1.76.
PE Ratio
Bio-Techne Corp has a trailing twelve months price to earnings ratio of 39.53. Meaning, the purchaser of the share is investing $39.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.57%.
Yearly Top and Bottom Value
Bio-Techne Corp’s stock is valued at $69.57 at 22:29 EST, way below its 52-week high of $90.63 and above its 52-week low of $65.77.
Volatility
Bio-Techne Corp’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.57%, a negative 0.27%, and a positive 1.31%.
Bio-Techne Corp’s highest amplitude of average volatility was 0.85% (last week), 0.97% (last month), and 1.31% (last quarter).
Volume
Today’s last reported volume for Bio-Techne Corp is 285686 which is 65.29% below its average volume of 823175.
More news about Bio-Techne Corp.
9. Zillow Group (Z)
Zillow Group has been having an accuracy rate of 83.64% over the last 10 sessions. Previous close price was $44.54 the AI prediction was $45.39 and today’s closing price was $45.31. The intraday ROI for Zillow Group (Z) was 1.73%.
Shares of Zillow Group dropped by a staggering 15.01% in from $52.59 to $44.70 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is jumping 0.58% to $13,562.84, after three consecutive sessions in a row of gains.
Zillow Group, Inc. operates real estate brands on mobile applications and Websites in the United States.
Earnings Per Share
As for profitability, Zillow Group has a trailing twelve months EPS of $-0.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.93%.
More news about Zillow Group.
10. Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals has been having an accuracy rate of 88.18% over the last 10 sessions. Previous close price was $166.34 the AI prediction was $172.81 and today’s closing price was $169.06. The intraday ROI for Alnylam Pharmaceuticals (ALNY) was 1.64%.
Shares of Alnylam Pharmaceuticals fell by a staggering 19.45% in from $210.79 to $169.79 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.58% to $13,562.84, after three sequential sessions in a row of gains.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.
Earnings Per Share
As for profitability, Alnylam Pharmaceuticals has a trailing twelve months EPS of $-8.13.
Volume
Today’s last reported volume for Alnylam Pharmaceuticals is 407961 which is 31.03% below its average volume of 591525.
Yearly Top and Bottom Value
Alnylam Pharmaceuticals’s stock is valued at $169.79 at 22:29 EST, way below its 52-week high of $242.97 and above its 52-week low of $167.40.
Volatility
Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.16%, a negative 1.03%, and a positive 1.73%.
Alnylam Pharmaceuticals’s highest amplitude of average volatility was 3.92% (last week), 2.71% (last month), and 1.73% (last quarter).
More news about Alnylam Pharmaceuticals.
11. Xerox Corporation (XRX)
Xerox Corporation has been having an accuracy rate of 89.34% over the last 10 sessions. Previous close price was $15.19 the AI prediction was $14.92 and today’s closing price was $14.99. The intraday ROI for Xerox Corporation (XRX) was 1.32%.
Shares of Xerox Corporation dropped by a staggering 11.69% in from $17.04 to $15.05 at 22:29 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.86% to $15,450.24, after five sequential sessions in a row of gains.
Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the Americas, Europe, the Middle East, Africa, India, and internationally.
Earnings Per Share
As for profitability, Xerox Corporation has a trailing twelve months EPS of $-1.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.45%.
Yearly Top and Bottom Value
Xerox Corporation’s stock is valued at $15.05 at 22:29 EST, way below its 52-week high of $18.00 and way higher than its 52-week low of $11.80.
Volume
Today’s last reported volume for Xerox Corporation is 471538 which is 72.84% below its average volume of 1736370.
More news about Xerox Corporation.
12. Graham Holdings Company (GHC)
Graham Holdings Company has been having an accuracy rate of 83.36% over the last 10 sessions. Previous close price was $589.14 the AI prediction was $598.88 and today’s closing price was $596.67. The intraday ROI for Graham Holdings Company (GHC) was 1.28%.
Shares of Graham Holdings Company jumped 3.32% in from $576.39 to $595.53 at 22:29 EST on Tuesday, after two successive sessions in a row of gains. NYSE is rising 0.86% to $15,450.24, after five sequential sessions in a row of gains.
Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally.
Earnings Per Share
As for profitability, Graham Holdings Company has a trailing twelve months EPS of $44.72.
PE Ratio
Graham Holdings Company has a trailing twelve months price to earnings ratio of 13.32. Meaning, the purchaser of the share is investing $13.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.
Volatility
Graham Holdings Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.31%, 0.14%, and 0.85%.
Graham Holdings Company’s highest amplitude of average volatility was 0.57% (last week), 0.81% (last month), and 0.85% (last quarter).
More news about Graham Holdings Company.
13. Dow Chemical Company (DOW)
Dow Chemical Company has been having an accuracy rate of 84.26% over the last 10 sessions. Previous close price was $50.69 the AI prediction was $50.8 and today’s closing price was $51.31. The intraday ROI for Dow Chemical Company (DOW) was 1.22%.
Shares of Dow Chemical Company dropped 4.73% in from $54.11 to $51.55 at 22:29 EST on Tuesday, after three successive sessions in a row of gains. NYSE is jumping 0.86% to $15,450.24, after five successive sessions in a row of gains.
Dow Inc., through its subsidiaries, engages in the provision of various materials science solutions for packaging, infrastructure, mobility, and consumer applications in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America.
Earnings Per Share
As for profitability, Dow Chemical Company has a trailing twelve months EPS of $2.45.
PE Ratio
Dow Chemical Company has a trailing twelve months price to earnings ratio of 21.04. Meaning, the purchaser of the share is investing $21.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.17%.
Yearly Top and Bottom Value
Dow Chemical Company’s stock is valued at $51.55 at 22:29 EST, way under its 52-week high of $60.88 and way higher than its 52-week low of $42.91.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Dow Chemical Company’s EBITDA is 33.1.
Volume
Today’s last reported volume for Dow Chemical Company is 1397420 which is 67.82% below its average volume of 4343420.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 29, 2023, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 5.62%.
More news about Dow Chemical Company.
14. Intuitive Surgical (ISRG)
Intuitive Surgical has been having an accuracy rate of 83.17% over the last 10 sessions. Previous close price was $294.54 the AI prediction was $302.69 and today’s closing price was $297.83. The intraday ROI for Intuitive Surgical (ISRG) was 1.12%.
Shares of Intuitive Surgical dropped 0.99% in from $301.82 to $298.83 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is jumping 0.58% to $13,562.84, after three consecutive sessions in a row of gains.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $3.97.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 75.27. Meaning, the purchaser of the share is investing $75.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.05%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Intuitive Surgical’s EBITDA is 250.39.
Yearly Top and Bottom Value
Intuitive Surgical’s stock is valued at $298.83 at 22:29 EST, way under its 52-week high of $358.07 and way higher than its 52-week low of $180.07.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 6.66B for the twelve trailing months.
Volume
Today’s last reported volume for Intuitive Surgical is 634668 which is 63.69% below its average volume of 1748270.
More news about Intuitive Surgical.
15. E.I. du Pont de Nemours and Company (DD)
E.I. du Pont de Nemours and Company has been having an accuracy rate of 83.43% over the last 10 sessions. Previous close price was $75.39 the AI prediction was $76.35 and today’s closing price was $76.23. The intraday ROI for E.I. du Pont de Nemours and Company (DD) was 1.11%.
Shares of E.I. du Pont de Nemours and Company rose 0.49% in from $76.02 to $76.39 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is jumping 0.86% to $15,450.24, after five sequential sessions in a row of gains.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
Earnings Per Share
As for profitability, E.I. du Pont de Nemours and Company has a trailing twelve months EPS of $2.03.
PE Ratio
E.I. du Pont de Nemours and Company has a trailing twelve months price to earnings ratio of 37.63. Meaning, the purchaser of the share is investing $37.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.82%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, E.I. du Pont de Nemours and Company’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for E.I. du Pont de Nemours and Company is 1156240 which is 52.42% below its average volume of 2430410.
More news about E.I. du Pont de Nemours and Company.
16. CME Group (CME)
CME Group has been having an accuracy rate of 88.86% over the last 10 sessions. Previous close price was $214.23 the AI prediction was $217.58 and today’s closing price was $216.09. The intraday ROI for CME Group (CME) was 0.87%.
Shares of CME Group rose 5.84% in from $205.87 to $217.89 at 22:29 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is rising 0.58% to $13,562.84, after three consecutive sessions in a row of gains.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
Earnings Per Share
As for profitability, CME Group has a trailing twelve months EPS of $8.19.
PE Ratio
CME Group has a trailing twelve months price to earnings ratio of 26.6. Meaning, the purchaser of the share is investing $26.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.67%.
More news about CME Group.
17. E.I. du Pont de Nemours and Company (DD)
E.I. du Pont de Nemours and Company has been having an accuracy rate of 83.43% over the last 10 sessions. Previous close price was $75.59 the AI prediction was $77.15 and today’s closing price was $76.23. The intraday ROI for E.I. du Pont de Nemours and Company (DD) was 0.85%.
Shares of E.I. du Pont de Nemours and Company jumped 0.49% in from $76.02 to $76.39 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is jumping 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
Earnings Per Share
As for profitability, E.I. du Pont de Nemours and Company has a trailing twelve months EPS of $2.03.
PE Ratio
E.I. du Pont de Nemours and Company has a trailing twelve months price to earnings ratio of 37.63. Meaning, the purchaser of the share is investing $37.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.82%.
Sales Growth
E.I. du Pont de Nemours and Company’s sales growth for the next quarter is negative 20.6%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
E.I. du Pont de Nemours and Company’s EBITDA is 48.93.
Volatility
E.I. du Pont de Nemours and Company’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.72%, a negative 0.01%, and a positive 0.83%.
E.I. du Pont de Nemours and Company’s highest amplitude of average volatility was 0.77% (last week), 0.77% (last month), and 0.83% (last quarter).
Moving Average
E.I. du Pont de Nemours and Company’s value is above its 50-day moving average of $75.28 and higher than its 200-day moving average of $71.92.
More news about E.I. du Pont de Nemours and Company.
18. Graham Holdings Company (GHC)
Graham Holdings Company has been having an accuracy rate of 88.47% over the last 10 sessions. Previous close price was $592.1 the AI prediction was $603.58 and today’s closing price was $596.67. The intraday ROI for Graham Holdings Company (GHC) was 0.77%.
Shares of Graham Holdings Company rose 3.32% in from $576.39 to $595.53 at 22:29 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is jumping 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally.
Earnings Per Share
As for profitability, Graham Holdings Company has a trailing twelve months EPS of $44.72.
PE Ratio
Graham Holdings Company has a trailing twelve months price to earnings ratio of 13.32. Meaning, the purchaser of the share is investing $13.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Graham Holdings Company’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Graham Holdings Company’s EBITDA is 13.45.
Volume
Today’s last reported volume for Graham Holdings Company is 2903 which is 82.76% below its average volume of 16843.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 4.21B for the twelve trailing months.
More news about Graham Holdings Company.
19. Biogen (BIIB)
Biogen has been having an accuracy rate of 84.06% over the last 10 sessions. Previous close price was $262.8 the AI prediction was $269.05 and today’s closing price was $264.14. The intraday ROI for Biogen (BIIB) was 0.51%.
Shares of Biogen jumped 2.28% in from $258.74 to $264.64 at 22:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is jumping 0.58% to $13,562.84, after three sequential sessions in a row of gains.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Earnings Per Share
As for profitability, Biogen has a trailing twelve months EPS of $18.65.
PE Ratio
Biogen has a trailing twelve months price to earnings ratio of 14.19. Meaning, the purchaser of the share is investing $14.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.25%.
Previous days news about Biogen
- Biogen inc. (biib) advances but underperforms market: key facts. According to Zacks on Monday, 9 October, "It is also important to note the recent changes to analyst estimates for Biogen Inc. Such recent modifications usually signify the changing landscape of near-term business trends. ", "Its industry sports an average Forward P/E of 17.38, so one might conclude that Biogen Inc. is trading at a discount comparatively."
More news about Biogen.
20. Ross Stores (ROST)
Ross Stores has been having an accuracy rate of 83.74% over the last 10 sessions. Previous close price was $112.94 the AI prediction was $115.87 and today’s closing price was $113.1. The intraday ROI for Ross Stores (ROST) was 0.14%.
Shares of Ross Stores slid 4.95% in from $119.43 to $113.52 at 22:29 EST on Tuesday, after three sequential sessions in a row of gains. NASDAQ is rising 0.58% to $13,562.84, after three successive sessions in a row of gains.
Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names in the United States.
Earnings Per Share
As for profitability, Ross Stores has a trailing twelve months EPS of $4.71.
PE Ratio
Ross Stores has a trailing twelve months price to earnings ratio of 24.1. Meaning, the purchaser of the share is investing $24.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.44%.
More news about Ross Stores.
21. Burlington Stores (BURL)
Burlington Stores has been having an accuracy rate of 88.71% over the last 10 sessions. Previous close price was $123.68 the AI prediction was $124.61 and today’s closing price was $123.72. The intraday ROI for Burlington Stores (BURL) was 0.03%.
Shares of Burlington Stores dropped by a staggering 25.84% in from $167.13 to $123.94 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is rising 0.86% to $15,450.24, after five successive sessions in a row of gains.
Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States.
Earnings Per Share
As for profitability, Burlington Stores has a trailing twelve months EPS of $3.98.
PE Ratio
Burlington Stores has a trailing twelve months price to earnings ratio of 31.14. Meaning, the purchaser of the share is investing $31.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.39%.
Sales Growth
Burlington Stores’s sales growth for the next quarter is 10.8%.
Moving Average
Burlington Stores’s worth is way below its 50-day moving average of $154.40 and way below its 200-day moving average of $182.59.
Volatility
Burlington Stores’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.56%, a negative 1.22%, and a positive 1.76%.
Burlington Stores’s highest amplitude of average volatility was 2.80% (last week), 2.17% (last month), and 1.76% (last quarter).
Volume
Today’s last reported volume for Burlington Stores is 381620 which is 69.78% below its average volume of 1263060.
More news about Burlington Stores.
22. FAT Brands (FAT)
FAT Brands has been having an accuracy rate of 83.58% over the last 10 sessions. Previous close price was $6.55 the AI prediction was $6.56 and today’s closing price was $6.53. The intraday ROI for FAT Brands (FAT) was -0.31%.
Shares of FAT Brands fell 1.06% in from $6.7 to $6.63 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is jumping 0.58% to $13,562.84, after three consecutive sessions in a row of gains.
FAT Brands Inc., a multi-brand restaurant company, acquires, develops, markets, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide.
Earnings Per Share
As for profitability, FAT Brands has a trailing twelve months EPS of $-8.09.
Volume
Today’s last reported volume for FAT Brands is 2565 which is 83.33% below its average volume of 15392.
Earnings Before Interest, Taxes, Depreciation, and Amortization
FAT Brands’s EBITDA is 49.59.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 9.9% and 62.8%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.9%, now sitting on 419.49M for the twelve trailing months.
More news about FAT Brands.
23. Pfizer (PFE)
Pfizer has been having an accuracy rate of 83.7% over the last 10 sessions. Previous close price was $33.28 the AI prediction was $34.02 and today’s closing price was $33.17. The intraday ROI for Pfizer (PFE) was -0.33%.
Shares of Pfizer slid 1.84% in from $33.86 to $33.24 at 22:29 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Earnings Per Share
As for profitability, Pfizer has a trailing twelve months EPS of $3.76.
PE Ratio
Pfizer has a trailing twelve months price to earnings ratio of 8.84. Meaning, the purchaser of the share is investing $8.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.07%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 54.1%, now sitting on 77.94B for the twelve trailing months.
Previous days news about Pfizer
- Pfizer (pfe) rises yet lags behind market: some facts worth knowing. According to Zacks on Monday, 9 October, "Any recent changes to analyst estimates for Pfizer should also be noted by investors. ", "Investors will be eagerly watching for the performance of Pfizer in its upcoming earnings disclosure. "
More news about Pfizer.
24. Banco Santander (SAN)
Banco Santander has been having an accuracy rate of 84.03% over the last 10 sessions. Previous close price was $3.8 the AI prediction was $3.8 and today’s closing price was $3.78. The intraday ROI for Banco Santander (SAN) was -0.53%.
Shares of Banco Santander jumped 3.28% in from $3.66 to $3.78 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is jumping 0.86% to $15,450.24, after five successive sessions in a row of gains.
Banco Santander, S.A. provides various retail and commercial banking products and services to individuals, small and medium-sized enterprises, and large companies worldwide.
Earnings Per Share
As for profitability, Banco Santander has a trailing twelve months EPS of $0.61.
PE Ratio
Banco Santander has a trailing twelve months price to earnings ratio of 6.2. Meaning, the purchaser of the share is investing $6.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.06%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Santander’s stock is considered to be overbought (>=80).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 3.18%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 42.92B for the twelve trailing months.
Volume
Today’s last reported volume for Banco Santander is 1651690 which is 49.01% below its average volume of 3239300.
More news about Banco Santander.
25. Live Nation Entertainment (LYV)
Live Nation Entertainment has been having an accuracy rate of 89.04% over the last 10 sessions. Previous close price was $87.15 the AI prediction was $89.8 and today’s closing price was $86.55. The intraday ROI for Live Nation Entertainment (LYV) was -0.69%.
Shares of Live Nation Entertainment jumped 5.67% in from $82.05 to $86.70 at 22:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is rising 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
Live Nation Entertainment, Inc. operates as a live entertainment company.
Earnings Per Share
As for profitability, Live Nation Entertainment has a trailing twelve months EPS of $1.11.
PE Ratio
Live Nation Entertainment has a trailing twelve months price to earnings ratio of 78.11. Meaning, the purchaser of the share is investing $78.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.18%.
Volume
Today’s last reported volume for Live Nation Entertainment is 594220 which is 71.75% below its average volume of 2103530.
Revenue Growth
Year-on-year quarterly revenue growth grew by 27%, now sitting on 19.2B for the twelve trailing months.
Moving Average
Live Nation Entertainment’s worth is above its 50-day moving average of $84.21 and above its 200-day moving average of $79.29.
More news about Live Nation Entertainment.
26. Nokia (NOK)
Nokia has been having an accuracy rate of 87.33% over the last 10 sessions. Previous close price was $3.57 the AI prediction was $3.42 and today’s closing price was $3.6. The intraday ROI for Nokia (NOK) was -0.84%.
Shares of Nokia slid by a staggering 12.71% in from $4.15 to $3.62 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is rising 0.86% to $15,450.24, after five consecutive sessions in a row of gains.
Nokia Oyj provides mobile, fixed, and cloud network solutions worldwide.
Earnings Per Share
As for profitability, Nokia has a trailing twelve months EPS of $0.77.
PE Ratio
Nokia has a trailing twelve months price to earnings ratio of 4.7. Meaning, the purchaser of the share is investing $4.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.58%.
Yearly Top and Bottom Value
Nokia’s stock is valued at $3.62 at 22:29 EST, way under its 52-week high of $5.11 and higher than its 52-week low of $3.50.
More news about Nokia.
27. Cadence Design Systems (CDNS)
Cadence Design Systems has been having an accuracy rate of 83.46% over the last 10 sessions. Previous close price was $247.53 the AI prediction was $244 and today’s closing price was $249.75. The intraday ROI for Cadence Design Systems (CDNS) was -0.9%.
Shares of Cadence Design Systems jumped 2.81% in from $243.03 to $249.86 at 22:29 EST on Tuesday, after three sequential sessions in a row of gains. NASDAQ is jumping 0.58% to $13,562.84, after three sequential sessions in a row of gains.
Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide.
Earnings Per Share
As for profitability, Cadence Design Systems has a trailing twelve months EPS of $3.31.
PE Ratio
Cadence Design Systems has a trailing twelve months price to earnings ratio of 75.49. Meaning, the purchaser of the share is investing $75.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.15%.
Sales Growth
Cadence Design Systems’s sales growth is 11% for the current quarter and 19.2% for the next.
More news about Cadence Design Systems.
28. Live Nation Entertainment (LYV)
Live Nation Entertainment has been having an accuracy rate of 84.01% over the last 10 sessions. Previous close price was $87.49 the AI prediction was $88.85 and today’s closing price was $86.55. The intraday ROI for Live Nation Entertainment (LYV) was -1.07%.
Shares of Live Nation Entertainment rose 5.67% in from $82.05 to $86.70 at 22:29 EST on Tuesday, after two consecutive sessions in a row of losses. NYSE is jumping 0.86% to $15,450.24, after five successive sessions in a row of gains.
Live Nation Entertainment, Inc. operates as a live entertainment company.
Earnings Per Share
As for profitability, Live Nation Entertainment has a trailing twelve months EPS of $1.11.
PE Ratio
Live Nation Entertainment has a trailing twelve months price to earnings ratio of 78.11. Meaning, the purchaser of the share is investing $78.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.18%.
Volume
Today’s last reported volume for Live Nation Entertainment is 594220 which is 71.75% below its average volume of 2103530.
More news about Live Nation Entertainment.
29. Globalstar (GSAT)
Globalstar has been having an accuracy rate of 83.48% over the last 10 sessions. Previous close price was $1.4 the AI prediction was $1.41 and today’s closing price was $1.38. The intraday ROI for Globalstar (GSAT) was -1.43%.
Shares of Globalstar fell 7.91% in from $1.51 to $1.39 at 22:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is rising 0.86% to $15,450.24, after five successive sessions in a row of gains.
Globalstar, Inc. provides mobile satellite services worldwide.
Earnings Per Share
As for profitability, Globalstar has a trailing twelve months EPS of $-0.12.
Volume
Today’s last reported volume for Globalstar is 1702970 which is 67.87% below its average volume of 5300300.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be oversold (<=20).
Volatility
Globalstar’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.98%, a negative 0.29%, and a positive 3.00%.
Globalstar’s highest amplitude of average volatility was 1.98% (last week), 2.89% (last month), and 3.00% (last quarter).
Sales Growth
Globalstar’s sales growth is 42.8% for the ongoing quarter and 31.6% for the next.
More news about Globalstar.
30. Sabre Corporation (SABR)
Sabre Corporation has been having an accuracy rate of 83.57% over the last 10 sessions. Previous close price was $3.88 the AI prediction was $3.5 and today’s closing price was $3.95. The intraday ROI for Sabre Corporation (SABR) was -1.8%.
Shares of Sabre Corporation fell by a staggering 23.79% in from $5.13 to $3.91 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.58% to $13,562.84, after three successive sessions in a row of gains.
Sabre Corporation, through its subsidiaries, provides software and technology solutions for the travel industry worldwide.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.67.
Moving Average
Sabre Corporation’s worth is way below its 50-day moving average of $4.78 and way below its 200-day moving average of $4.71.
More news about Sabre Corporation.
31. Ericsson (ERIC)
Ericsson has been having an accuracy rate of 88.21% over the last 10 sessions. Previous close price was $4.75 the AI prediction was $4.61 and today’s closing price was $4.85. The intraday ROI for Ericsson (ERIC) was -2.11%.
Shares of Ericsson slid 6.37% in from $5.2 to $4.87 at 22:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is rising 0.58% to $13,562.84, after three consecutive sessions in a row of gains.
Telefonaktiebolaget LM Ericsson (publ), together with its subsidiaries, provides communication infrastructure, services, and software solutions to the telecom and other sectors.
Earnings Per Share
As for profitability, Ericsson has a trailing twelve months EPS of $0.33.
PE Ratio
Ericsson has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing $14.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.63%.
Yearly Top and Bottom Value
Ericsson’s stock is valued at $4.87 at 22:29 EST, way under its 52-week high of $6.82 and above its 52-week low of $4.62.
Volume
Today’s last reported volume for Ericsson is 5967420 which is 30.06% below its average volume of 8532890.
More news about Ericsson.
32. Brandywine Realty Trust (BDN)
Brandywine Realty Trust has been having an accuracy rate of 87.83% over the last 10 sessions. Previous close price was $3.95 the AI prediction was $3.95 and today’s closing price was $4.08. The intraday ROI for Brandywine Realty Trust (BDN) was -3.29%.
Shares of Brandywine Realty Trust fell by a staggering 16.79% in from $4.94 to $4.11 at 22:29 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is jumping 0.86% to $15,450.24, after five sequential sessions in a row of gains.
Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets.
Earnings Per Share
As for profitability, Brandywine Realty Trust has a trailing twelve months EPS of $0.14.
PE Ratio
Brandywine Realty Trust has a trailing twelve months price to earnings ratio of 29.32. Meaning, the purchaser of the share is investing $29.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.57%.
Yearly Top and Bottom Value
Brandywine Realty Trust’s stock is valued at $4.11 at 22:29 EST, way below its 52-week high of $7.25 and way higher than its 52-week low of $3.42.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 2, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 15.38%.
Sales Growth
Brandywine Realty Trust’s sales growth is 3.1% for the current quarter and 2% for the next.
Volatility
Brandywine Realty Trust’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.01%, a negative 0.93%, and a positive 2.43%.
Brandywine Realty Trust’s highest amplitude of average volatility was 1.18% (last week), 2.94% (last month), and 2.43% (last quarter).
More news about Brandywine Realty Trust.
33. Antero Resources (AR)
Antero Resources has been having an accuracy rate of 88.35% over the last 10 sessions. Previous close price was $25.89 the AI prediction was $25.83 and today’s closing price was $27.13. The intraday ROI for Antero Resources (AR) was -4.79%.
Shares of Antero Resources rose 4.76% in from $26.07 to $27.31 at 22:29 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.86% to $15,450.24, after five sequential sessions in a row of gains.
Antero Resources Corporation, an independent oil and natural gas company, engages in the development, production, exploration, and acquisition of natural gas, natural gas liquids (NGLs), and oil properties in the United States.
Earnings Per Share
As for profitability, Antero Resources has a trailing twelve months EPS of $4.89.
PE Ratio
Antero Resources has a trailing twelve months price to earnings ratio of 5.58. Meaning, the purchaser of the share is investing $5.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.71%.
Volatility
Antero Resources’s last week, last month’s, and last quarter’s current intraday variation average was 4.65%, 0.25%, and 2.04%.
Antero Resources’s highest amplitude of average volatility was 4.65% (last week), 2.32% (last month), and 2.04% (last quarter).
Yearly Top and Bottom Value
Antero Resources’s stock is valued at $27.31 at 22:29 EST, way under its 52-week high of $40.19 and way higher than its 52-week low of $19.91.
More news about Antero Resources.
34. Sabre Corporation (SABR)
Sabre Corporation has been having an accuracy rate of 83.52% over the last 10 sessions. Previous close price was $3.76 the AI prediction was $3.5 and today’s closing price was $3.95. The intraday ROI for Sabre Corporation (SABR) was -5.05%.
Shares of Sabre Corporation dropped by a staggering 23.79% in from $5.13 to $3.91 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.58% to $13,562.84, after three successive sessions in a row of gains.
Sabre Corporation, through its subsidiaries, provides software and technology solutions for the travel industry worldwide.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.67.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sabre Corporation’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sabre Corporation’s EBITDA is -427.69.
Yearly Top and Bottom Value
Sabre Corporation’s stock is valued at $3.91 at 22:29 EST, way under its 52-week high of $7.92 and way above its 52-week low of $2.99.
More news about Sabre Corporation.
35. Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals has been having an accuracy rate of 83.27% over the last 10 sessions. Previous close price was $179.28 the AI prediction was $185.25 and today’s closing price was $169.06. The intraday ROI for Alnylam Pharmaceuticals (ALNY) was -5.7%.
Shares of Alnylam Pharmaceuticals fell by a staggering 19.45% in from $210.79 to $169.79 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is jumping 0.58% to $13,562.84, after three successive sessions in a row of gains.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.
Earnings Per Share
As for profitability, Alnylam Pharmaceuticals has a trailing twelve months EPS of $-8.13.
More news about Alnylam Pharmaceuticals.
